title: Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1beta secretion.
abstract: In healthy monocytes, Toll-like receptor (TLR) engagement induces production of reactive oxygen species (ROS), followed by an antioxidant response involved in IL-1beta processing and secretion. Markers of the antioxidant response include intracellular thioredoxin and extracellular release of reduced cysteine. Cryopyrin-associated periodic syndromes (CAPS) are autoinflammatory diseases in which Nod-like receptor family pyrin domain-containing 3 (NLRP3) gene mutations lead to increased IL-1beta secretion. We show in a large cohort of patients that IL-1beta secretion by CAPS monocytes is much faster than that by healthy monocytes. This accelerated kinetics is caused by alterations in the basal redox state, as well as in the redox response to TLR triggering displayed by CAPS monocytes. Indeed, unstimulated CAPS monocytes are under a mild oxidative stress, with elevated levels of both ROS and antioxidants. The redox response to LPS is quickened, with early generation of the reducing conditions favoring IL-1beta processing and secretion, and then rapidly exhausted. Therefore, secretion of IL-1beta is accelerated, but reaches a plateau much earlier than in healthy controls. Pharmacologic inhibition of the redox response hinders IL-1beta release, confirming the functional link between redox impairment and altered kinetics of secretion. Monocytes from patients with juvenile idiopathic arthritis display normal kinetics of redox response and IL-1beta secretion, excluding a role of chronic inflammation in the alterations observed in CAPS. We conclude that preexisting redox alterations distinct from CAPS monocytes anticipate the pathogen-associated molecular pattern molecule-induced generation of the reducing environment favorable to inflammasome activation and IL-1beta secretion.
authors.affiliation: Cell Biology Unit, National Cancer Research Institute, 16132 Genoa, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Tassi
authors.forename: Sonia
authors.initials: S
authors.lastname: Carta
authors.forename: Laura
authors.initials: L
authors.lastname: Delfino
authors.forename: Roberta
authors.initials: R
authors.lastname: Caorsi
authors.forename: Alberto
authors.initials: A
authors.lastname: Martini
authors.forename: Marco
authors.initials: M
authors.lastname: Gattorno
authors.forename: Anna
authors.initials: A
authors.lastname: Rubartelli
mesh_terms: D002478:Cells, Cultured; D056587:Cryopyrin-Associated Periodic Syndromes / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D053583:Interleukin-1beta / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000276:immunology; D009000:Monocytes / Q000276:immunology / Q000378:metabolism*; D010084:Oxidation-Reduction; D018384:Oxidative Stress
chemical_list: D053583:Interleukin-1beta; D008070:Lipopolysaccharides
references.citation: Eur J Immunol. 2008 Sep;38(9):2419-25
references.pmid: 18792398
references.citation: J Exp Med. 2005 May 2;201(9):1479-86
references.pmid: 15851489
references.citation: Nat Chem Biol. 2009 Oct;5(10):709-10
references.pmid: 19763100
references.citation: Arthritis Rheum. 2008 May;58(5):1505-15
references.pmid: 18438814
references.citation: J Exp Med. 1995 Sep 1;182(3):751-8
references.pmid: 7650482
references.citation: Blood. 2004 Apr 1;103(7):2809-15
references.pmid: 14630794
references.citation: Arthritis Rheum. 2007 Sep;56(9):3138-48
references.pmid: 17763411
references.citation: J Biol Chem. 2007 Feb 2;282(5):2871-9
references.pmid: 17132626
references.citation: Immunity. 2004 Mar;20(3):319-25
references.pmid: 15030775
references.citation: Blood. 2006 Mar 15;107(6):2501-6
references.pmid: 16291594
references.citation: Science. 2008 May 2;320(5876):674-7
references.pmid: 18403674
references.citation: Annu Rev Immunol. 2009;27:519-50
references.pmid: 19302047
references.citation: Blood. 2008 Feb 15;111(4):2132-41
references.pmid: 18063752
references.citation: N Engl J Med. 2006 Aug 10;355(6):581-92
references.pmid: 16899778
references.citation: Arthritis Rheum. 2002 Dec;46(12):3340-8
references.pmid: 12483741
references.citation: Annu Rev Immunol. 2009;27:229-65
references.pmid: 19302040
references.citation: Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1491-6
references.pmid: 11792859
references.citation: J Neurosci. 2009 May 6;29(18):5910-5
references.pmid: 19420257
references.citation: J Leukoc Biol. 2009 Sep;86(3):549-55
references.pmid: 19564570
references.citation: J Immunol. 2008 Jun 15;180(12):8410-20
references.pmid: 18523309
references.citation: Antioxid Redox Signal. 2007 Jan;9(1):25-47
references.pmid: 17115886
references.citation: Brain Res. 2009 Jul 7;1279:99-108
references.pmid: 19409882
references.citation: J Biol Chem. 1999 Apr 23;274(17):11455-8
references.pmid: 10206947
references.citation: Arthritis Rheum. 2004 Oct;50(10):3329-33
references.pmid: 15476236
references.citation: Nat Immunol. 2008 Aug;9(8):866-72
references.pmid: 18604212
references.citation: Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8067-72
references.pmid: 18523012
references.citation: Oncogene. 2008 Mar 6;27(11):1618-28
references.pmid: 17828297
references.citation: Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11400-5
references.pmid: 19549867
references.citation: J Exp Med. 2009 May 11;206(5):1029-36
references.pmid: 19364880
references.citation: J Immunol. 2009 Jul 15;183(2):1456-62
references.pmid: 19561107
references.citation: Rheumatology (Oxford). 2007 Mar;46(3):473-8
references.pmid: 16920754
references.citation: Annu Rev Immunol. 2009;27:621-68
references.pmid: 19302049
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609